Turkish Journal of Physical Medicine and Rehabilitation
Evaluation of the effects of neural therapy in patients diagnosed with fibromyalgia
Turgay Altınbilek 1 ,Rabia Terzi 2 ,Aynur Başaran 3 ,Sena Tolu 1 ,Seher Küçüksaraç 1
1 Department of Physiotherapy and Rehabilitation, İstanbul Kültür University, Faculty of Health Sciences, İstanbul, Turkey
2 Department of Physical Therapy and Rehabilitation, Health Sciences University, Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey
3 Department of Physical Therapy and Rehabilitation, Special Ozlem Physical Therapy and Rehabilitation Center, Konya, Turkey
DOI : 10.5606/tftrd.2019.1931 Objectives: The objective of this study is to compare effects of neural therapy and exercise on pain, quality of life (QoL), depression, anxiety and functioning status in patients diagnosed with FMS.

Patients and methods: The study was conducted on 72 patients (60 females and 12 males) diagnosed with FMS according to the 1990ACR criteria. Patients were randomized and divided into two groups. The first treatment group (n=30) received an exercise program (strengthening, stretching, relaxation and aerobic exercises, 3 days a week), while the second treatment group (n=42) received total 6 sessions of neural therapy as 1 session a week in addition to the same exercise program. Pain levels were assessed with the visual analog scale, emotional state with Beck depression and Beck anxiety scales, quality of life with SF 36 and functioning status with Fibromyalgia Impact Questionnaire (FIQ). Precision points of the patients were further assessed. The patients were evaluated at the end of treatment (week 6) and one month after the end of treatment.

Results: The mean age was found as 39,2±9,5 years (mean±SD), the mean disease duration as 34,3±9,3 months (mean±SD), the mean VAS score as 7,28±2,24(mean±SD) and the mean FIQ score as 58,42±13,24. No statistically significant difference was found between the groups in terms of age, gender, disease duration, smoking, marital status and educational status. There were significant improvements in both groups between the evaluations carried out before and after the treatment in terms of VAS, FIQ, SF-36, Beck anxiety and Beck depression scales (p<0.05). Posttreatment Beck depression score and VAS scores significantly lower in neural therapy groups. (p=0,038; p=0.049; p<0,05). There was no significant difference between the groups in all parameters one month after the end of treatment.(p>0.05)

Conclusion: When combined with neural therapy and exercise in fibromyalgia patients, it may be advantageous early in terms of pain and depression compared to exercise only. Further work is needed for the long term effectiveness. Keywords : Fibromyalgia; lidokain; neural therapy; treatment